Cargando…
A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor
Glucocorticoids (GCs)—ligands of the glucocorticoid receptor (GR)—are widely used to treat inflammatory diseases, but suffer from significant side effects and poor responsiveness in certain patient populations. Identification of chemical GR modulators may provide insights into the regulatory mechani...
Autores principales: | Jiang, Xiaofeng, Dahlin, Amber, Weiss, Scott T., Tantisira, Kelan, Lu, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547123/ https://www.ncbi.nlm.nih.gov/pubmed/28785063 http://dx.doi.org/10.1038/s41598-017-07565-2 |
Ejemplares similares
-
Drug Repurposing to Treat Glucocorticoid Resistance in Asthma
por: Wang, Alberta L., et al.
Publicado: (2021) -
Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses
por: Tantisira, Kelan G, et al.
Publicado: (2001) -
RNA-Seq Transcriptome Profiling Identifies CRISPLD2 as a Glucocorticoid Responsive Gene that Modulates Cytokine Function in Airway Smooth Muscle Cells
por: Himes, Blanca E., et al.
Publicado: (2014) -
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma
por: Dahlin, Amber, et al.
Publicado: (2015) -
Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes
por: Choi, Jihoon, et al.
Publicado: (2018)